Individuals who may warrant closer monitoring include: Those with a personal or family history of depression , anxiety, or other mood disorders People who have previously experienced mood changes on other weight-loss medications or GLP-1-based therapies Individuals with eating disorders or a complex relationship with food , for whom appetite suppression may have psychological implications (see NICE guideline NG69: Eating disorders: recognition and treatment) [10] Those experiencing significant life stressors alongside starting a new treatment People with poorly controlled type 2 diabetes , where fluctuating blood glucose levels both hypoglycaemia and hyperglycaemia can independently affect mood, concentration, and emotional wellbeing It is also worth acknowledging that obesity itself is associated with higher rates of depression and anxiety, and that the psychological experience of rapid body weight change whether positive or negative can be emotionally complex
Diabetes urine smell is often described as sweet, fruity, or unusually strong, but smell alone does not diagnose diabetes
This includes checking lab results and symptoms
All procedures performed were in accordance with the relevant guidelines and regulations
Since first-generation GLP-1 aids weight loss by mildly reducing appetite, the Points Program is recommended for people taking those medications
Studies show it impacts energy, insulin, and hormone levels
